Exposing Therapeutic Vulnerabilities in Cancer through Bioinformatics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Informatics".
Deadline for manuscript submissions: closed (28 February 2021) | Viewed by 2380
Special Issue Editor
Special Issue Information
Dear Colleagues,
Modern advances in genomic technologies have led to effective therapies against tumors with specific mutations. However, in a majority of cases, identifications of genomic alterations that dictate the fate of tumors and can be effectively targeted remain elusive. Additionally, while current immunotherapy-based approaches—such as immune checkpoint-blockade therapies—have resulted in improved survival in many patients, these therapies have significant liabilities due to the unpredictability of patient response and their high toxicity. This Special Issue of IJMS will discuss pathway/systems biology approaches aimed at the identification of tumor vulnerabilities to targeted or immune-based therapy. Topics include but are not limited to approaches that:
- Predict tumor response/resistance to standard of care drugs;
- Identify effective combinatorial therapies;
- Predict the effectiveness of alternative approaches such as fasting or ascorbic acid therapy;
- Develop immunograms that predict patient response to immune-based therapies;
- Predict individualized based toxicity in standard of care therapies.
Dr. Farhad Kosari
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- systems biology
- pathway analysis
- immunograms
- drug toxicity
- combinatorial therapies
- individualized therapy
- responders and nonresponders
